 | • レポートコード：GIR201110422 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ウイルスベクターワクチンの世界市場を調査対象にし、ウイルスベクターワクチンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アデノウイルス、鶏痘ウイルス、黄熱病弱毒化、ワクシニアウイルスベクター、その他）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Advanced Bioscience Laboratories、Creative Biogene、Boehringer Ingelheim、Sanofi、Brammer Bio、Pfizer、GE Healthcare ・メーカー別販売量、売上、市場シェア ・ウイルスベクターワクチンの地域別市場分析 ・ウイルスベクターワクチンの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ウイルスベクターワクチンのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ウイルスベクターワクチンのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ウイルスベクターワクチンの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ウイルスベクターワクチンの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ウイルスベクターワクチンの種類別市場規模2015-2020：アデノウイルス、鶏痘ウイルス、黄熱病弱毒化、ワクシニアウイルスベクター、その他 ・ウイルスベクターワクチンの用途別市場規模2015-2020：病院、診療所、その他 ・ウイルスベクターワクチンの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Viral Vector Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Viral Vector Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Viral Vector Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Viral Vector Vaccines market has been segmented into
Adenovirus
Fowlpox Virus
Attenuated Yellow Fever
Vaccinia Virus Vectors
Others
By Application, Viral Vector Vaccines has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Viral Vector Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Viral Vector Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Viral Vector Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Viral Vector Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Viral Vector Vaccines Market Share Analysis
Viral Vector Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Viral Vector Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Viral Vector Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Viral Vector Vaccines are:
Advanced Bioscience Laboratories
Creative Biogene
Boehringer Ingelheim
Sanofi
Brammer Bio
Pfizer
GE Healthcare
Among other players domestic and global, Viral Vector Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Viral Vector Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Viral Vector Vaccines, with price, sales, revenue and global market share of Viral Vector Vaccines in 2018 and 2019.
Chapter 3, the Viral Vector Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Viral Vector Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Viral Vector Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Viral Vector Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Viral Vector Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Viral Vector Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Adenovirus
1.2.3 Fowlpox Virus
1.2.4 Attenuated Yellow Fever
1.2.5 Vaccinia Virus Vectors
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Viral Vector Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Viral Vector Vaccines Market
1.4.1 Global Viral Vector Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advanced Bioscience Laboratories
2.1.1 Advanced Bioscience Laboratories Details
2.1.2 Advanced Bioscience Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advanced Bioscience Laboratories SWOT Analysis
2.1.4 Advanced Bioscience Laboratories Product and Services
2.1.5 Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Creative Biogene
2.2.1 Creative Biogene Details
2.2.2 Creative Biogene Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Creative Biogene SWOT Analysis
2.2.4 Creative Biogene Product and Services
2.2.5 Creative Biogene Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Boehringer Ingelheim SWOT Analysis
2.3.4 Boehringer Ingelheim Product and Services
2.3.5 Boehringer Ingelheim Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sanofi SWOT Analysis
2.4.4 Sanofi Product and Services
2.4.5 Sanofi Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Brammer Bio
2.5.1 Brammer Bio Details
2.5.2 Brammer Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Brammer Bio SWOT Analysis
2.5.4 Brammer Bio Product and Services
2.5.5 Brammer Bio Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GE Healthcare SWOT Analysis
2.7.4 GE Healthcare Product and Services
2.7.5 GE Healthcare Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Viral Vector Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Viral Vector Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Viral Vector Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Viral Vector Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Viral Vector Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Viral Vector Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Viral Vector Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Viral Vector Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Viral Vector Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Viral Vector Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Viral Vector Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Viral Vector Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Viral Vector Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Viral Vector Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Viral Vector Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Viral Vector Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Viral Vector Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Viral Vector Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Viral Vector Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Viral Vector Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Viral Vector Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Viral Vector Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Viral Vector Vaccines Sales and Growth Rate (2015-2020)
6.4 France Viral Vector Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Viral Vector Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Viral Vector Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Viral Vector Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Viral Vector Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7.5 India Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Viral Vector Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Viral Vector Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Viral Vector Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Viral Vector Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Viral Vector Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Viral Vector Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Viral Vector Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Viral Vector Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Viral Vector Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Viral Vector Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Viral Vector Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Viral Vector Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Viral Vector Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Viral Vector Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Viral Vector Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Viral Vector Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Viral Vector Vaccines Price by Type (2015-2020)
11 Global Viral Vector Vaccines Market Segment by Application
11.1 Global Viral Vector Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Viral Vector Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Viral Vector Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Viral Vector Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Viral Vector Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Viral Vector Vaccines Market Forecast (2021-2025)
12.2.2 Europe Viral Vector Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Viral Vector Vaccines Market Forecast (2021-2025)
12.2.4 South America Viral Vector Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Viral Vector Vaccines Market Forecast (2021-2025)
12.3 Viral Vector Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Viral Vector Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Viral Vector Vaccines Market Share Forecast by Type (2021-2025)
12.4 Viral Vector Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Viral Vector Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Viral Vector Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Viral Vector Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Viral Vector Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Viral Vector Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Advanced Bioscience Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Advanced Bioscience Laboratories Viral Vector Vaccines Major Business
Table 9. Advanced Bioscience Laboratories Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 10. Advanced Bioscience Laboratories SWOT Analysis
Table 11. Advanced Bioscience Laboratories Viral Vector Vaccines Product and Services
Table 12. Advanced Bioscience Laboratories Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Creative Biogene Basic Information, Manufacturing Base and Competitors
Table 14. Creative Biogene Viral Vector Vaccines Major Business
Table 15. Creative Biogene Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 16. Creative Biogene SWOT Analysis
Table 17. Creative Biogene Viral Vector Vaccines Product and Services
Table 18. Creative Biogene Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Viral Vector Vaccines Major Business
Table 21. Boehringer Ingelheim Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 22. Boehringer Ingelheim SWOT Analysis
Table 23. Boehringer Ingelheim Viral Vector Vaccines Product and Services
Table 24. Boehringer Ingelheim Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Sanofi Basic Information, Manufacturing Base and Competitors
Table 26. Sanofi Viral Vector Vaccines Major Business
Table 27. Sanofi Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 28. Sanofi SWOT Analysis
Table 29. Sanofi Viral Vector Vaccines Product and Services
Table 30. Sanofi Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Brammer Bio Basic Information, Manufacturing Base and Competitors
Table 32. Brammer Bio Viral Vector Vaccines Major Business
Table 33. Brammer Bio Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 34. Brammer Bio SWOT Analysis
Table 35. Brammer Bio Viral Vector Vaccines Product and Services
Table 36. Brammer Bio Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Pfizer Basic Information, Manufacturing Base and Competitors
Table 38. Pfizer Viral Vector Vaccines Major Business
Table 39. Pfizer Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 40. Pfizer SWOT Analysis
Table 41. Pfizer Viral Vector Vaccines Product and Services
Table 42. Pfizer Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. GE Healthcare Viral Vector Vaccines Major Business
Table 45. GE Healthcare Viral Vector Vaccines Total Revenue (USD Million) (2018-2019)
Table 46. GE Healthcare SWOT Analysis
Table 47. GE Healthcare Viral Vector Vaccines Product and Services
Table 48. GE Healthcare Viral Vector Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Viral Vector Vaccines Sales by Manufacturer (2018-2019) (K Units)
Table 50. Global Viral Vector Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Viral Vector Vaccines Sales by Regions (2015-2020) (K Units)
Table 52. Global Viral Vector Vaccines Sales Market Share by Regions (2015-2020)
Table 53. Global Viral Vector Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Viral Vector Vaccines Sales by Countries (2015-2020) (K Units)
Table 55. North America Viral Vector Vaccines Sales Market Share by Countries (2015-2020)
Table 56. North America Viral Vector Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Viral Vector Vaccines Revenue Market Share by Countries (2015-2020)
Table 58. Europe Viral Vector Vaccines Sales by Countries (2015-2020) (K Units)
Table 59. Europe Viral Vector Vaccines Sales Market Share by Countries (2015-2020)
Table 60. Europe Viral Vector Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Viral Vector Vaccines Sales by Regions (2015-2020) (K Units)
Table 62. Asia-Pacific Viral Vector Vaccines Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Viral Vector Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Viral Vector Vaccines Sales by Countries (2015-2020) (K Units)
Table 65. South America Viral Vector Vaccines Sales Market Share by Countries (2015-2020)
Table 66. South America Viral Vector Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Viral Vector Vaccines Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Viral Vector Vaccines Sales by Countries (2015-2020) (K Units)
Table 69. Middle East & Africa Viral Vector Vaccines Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Viral Vector Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Viral Vector Vaccines Revenue Market Share by Countries (2015-2020)
Table 72. Global Viral Vector Vaccines Sales by Type (2015-2020) (K Units)
Table 73. Global Viral Vector Vaccines Sales Share by Type (2015-2020)
Table 74. Global Viral Vector Vaccines Revenue by Type (2015-2020) (USD Million)
Table 75. Global Viral Vector Vaccines Revenue Share by Type (2015-2020)
Table 76. Global Viral Vector Vaccines Sales by Application (2015-2020) (K Units)
Table 77. Global Viral Vector Vaccines Sales Share by Application (2015-2020)
Table 78. Global Viral Vector Vaccines Sales Forecast by Regions (2021-2025) (K Units)
Table 79. Global Viral Vector Vaccines Market Share Forecast by Regions (2021-2025)
Table 80. Global Viral Vector Vaccines Sales Forecast by Type (2021-2025) (K Units)
Table 81. Global Viral Vector Vaccines Market Share Forecast by Type (2021-2025)
Table 82. Global Viral Vector Vaccines Sales Forecast by Application (2021-2025)
Table 83. Global Viral Vector Vaccines Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Viral Vector Vaccines Picture
Figure 2. Global Sales Market Share of Viral Vector Vaccines by Type in 2019
Figure 3. Adenovirus Picture
Figure 4. Fowlpox Virus Picture
Figure 5. Attenuated Yellow Fever Picture
Figure 6. Vaccinia Virus Vectors Picture
Figure 7. Others Picture
Figure 8. Viral Vector Vaccines Sales Market Share by Application in 2018
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global Viral Vector Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Viral Vector Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Viral Vector Vaccines Sales Market Share by Manufacturer in 2019
Figure 33. Global Viral Vector Vaccines Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Viral Vector Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Viral Vector Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Viral Vector Vaccines Revenue Market Share by Regions (2015-2020)
Figure 40. Global Viral Vector Vaccines Revenue Market Share by Regions in 2018
Figure 41. North America Viral Vector Vaccines Sales and Growth Rate (2015-2020)
Figure 42. Europe Viral Vector Vaccines Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Viral Vector Vaccines Sales and Growth Rate (2015-2020)
Figure 44. South America Viral Vector Vaccines Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Viral Vector Vaccines Sales and Growth Rate (2015-2020)
Figure 46. North America Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Viral Vector Vaccines Sales Market Share by Countries (2015-2020)
Figure 48. North America Viral Vector Vaccines Sales Market Share by Countries in 2018
Figure 49. North America Viral Vector Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Viral Vector Vaccines Revenue Market Share by Countries in 2018
Figure 51. United States Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Viral Vector Vaccines Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Viral Vector Vaccines Revenue Market Share by Countries in 2019
Figure 57. Germany Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Viral Vector Vaccines Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Viral Vector Vaccines Revenue Market Share by Regions 2019
Figure 65. China Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Viral Vector Vaccines Sales Market Share by Countries in 2019
Figure 72. South America Viral Vector Vaccines Revenue Market Share by Countries in 2019
Figure 73. Brazil Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Viral Vector Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Viral Vector Vaccines Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Viral Vector Vaccines Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Viral Vector Vaccines Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Viral Vector Vaccines Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Viral Vector Vaccines Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Viral Vector Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Viral Vector Vaccines Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Viral Vector Vaccines Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Viral Vector Vaccines Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Viral Vector Vaccines Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Viral Vector Vaccines Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
豚コレラワクチンの世界市場 2020年 Market Overview The Classical Swine Fever Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 酵母発現ベクターの世界市場 2020年 Market Overview The global Yeast Expression Vector market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Yeast Expression Vect…
- ベクトル変調器の世界市場 2020年 Market Overview The global Vector Modulators market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vector Modulators market re…
- コンパニオンアニマル用ワクチンの世界市場 2020年 Market Overview The global Companion Animal Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Companion Animal Va…